Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
5(100.0%)
5Total
N/A(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT06411418Not ApplicableActive Not Recruiting

Evaluation of Flow Diverter Technology Device for Intracranial Aneurysm

Role: lead

NCT06793059Not ApplicableRecruiting

Evaluation of Flow Diverter Technology Device for Intracranial Aneurysm (SHIELD)

Role: lead

NCT06447116Not ApplicableActive Not Recruiting

An EFS to Evaluate the CGuard Prime™ Carotid Stent in Acute Ischemic Stroke

Role: lead

NCT07140731Not ApplicableRecruiting

The Symani Restore Study

Role: lead

NCT05074186Not ApplicableCompleted

Assessing the Safety and Effectiveness of a Neurological Thrombectomy Medical Device for Acute Ischemic Stroke

Role: lead

All 5 trials loaded